News in a nutshell

Pharma research jobs on the chopping blockAnnouncements of job loss in big pharma continue, with the UK press saying that GlaxoSmithKline will soon announce 4,000 layoffs, nearly half in R&D. linkurl:(The Guardian);http://business.timesonline.co.uk/tol/business/industry_sectors/health/article7010418.ece AstraZeneca said last week it would cut 8000 jobs, 3,500 of them in R&D, and noted plans to outsource more of its research and trim the number of disease areas on which the company focuses. linku

Alla Katsnelson
Jan 31, 2010
Pharma research jobs on the chopping block
Announcements of job loss in big pharma continue, with the UK press saying that GlaxoSmithKline will soon announce 4,000 layoffs, nearly half in R&D. linkurl:(The Guardian);http://business.timesonline.co.uk/tol/business/industry_sectors/health/article7010418.ece AstraZeneca said last week it would cut 8000 jobs, 3,500 of them in R&D, and noted plans to outsource more of its research and trim the number of disease areas on which the company focuses. linkurl:(Wall Street Journal Health Blog);http://blogs.wsj.com/health/2010/01/28/astrazeneca-to-cut-another-8000-jobs/
Image: Wikipedia
FDA slaps doc for skin treatment statements
In a rare case of the agency censuring an individual rather than a company, the US Food and Drug Administration issued a warning letter to Miami Beach clinical researcher and dermatologist Leslie Baumann for "expressing premature enthusiasm" over a not-yet-approved injectible anti-wrinkle drug, the New York Times linkurl:reports.;http://www.nytimes.com/2010/02/01/business/01wrinkle.html?ref=health The linkurl:letter,;http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM198400.pdf issued last month, says Baumann improperly promoted the drug in statements to the media in...
Stem cells: an approval and some grants
A homeopathy protest
The IndependentPhD thesis, anyone?
not



Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?